Keyphrases
Cisplatin
100%
Epirubicin
100%
Advanced Biliary Tract Cancer
100%
Uracil-tegafur
100%
Leucovorin
100%
Confidence Interval
75%
Biliary Tract
50%
Tumor
25%
Patient Survival
25%
Phase II Study
25%
Partial Response
25%
Neutropenia
25%
Thrombocytopenia
25%
Median Survival
25%
Response Rate
25%
Treatment Modalities
25%
Disease Progression
25%
Outpatient Care
25%
Dose-limiting Toxicity
25%
Combined Regimen
25%
Advanced Malignancies
25%
Gallbladder Cancer
25%
Fatal Infection
25%
Median Time
25%
Therapeutic Modalities
25%
Intention-to-treat Analysis
25%
Biliary Tract Carcinoma
25%
Medicine and Dentistry
Cisplatin
100%
Epirubicin
100%
Cholangiocarcinoma
100%
Folinic Acid
100%
UFT
100%
Disease
75%
Hepatobiliary System
50%
Neoplasm
25%
Cancer
25%
Disease Exacerbation
25%
Gallbladder Carcinoma
25%
Intention-to-Treat Analysis
25%
Therapeutic Modality
25%
Neutropenia
25%
Outpatient Care
25%
Thrombocytopenia
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Bile Duct Carcinoma
100%
Folinic Acid
100%
Epirubicin
100%
UFT
100%
Disease
75%
Neoplasm
25%
Thrombocytopenia
25%
Neutropenia
25%
Disease Exacerbation
25%
Gallbladder Carcinoma
25%